Hypersensitivity reactions to gadolinium-based contrast agents studied
The rate of hypersensitivity reactions (HSRs) to gadolinium-based contrast agents (GBCAs) is 0.4 percent, and premedication can reduce the risk for HSRs in patients with a history of acute or delayed HSRs, according to a ...
May 4, 2022
0
2